Private Market View

Vitrivax

Discovery Tools (Healthcare) · Boulder, CO · Founded 2014 · Privately Held (backing)

Last price · $/share
Implied valuation
$69.4M
Total raised
$38.2M
Last round
Later Stage VC (Series B)
Nov 2025
What is Vitrivax worth?
$69.4Mlast known valuation

Vitrivax last raised $29.4M in its Later Stage VC (Series B) (Nov 2025).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 15 names
  • ·Watchlist + deal alerts for Vitrivax
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Nov 2025Later Stage VC (Series B)$29.4M

How Vitrivax's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Vitrivax, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Vitrivax worth?
Vitrivax's last known valuation is $69.4M.
How much has Vitrivax raised?
Vitrivax has raised $38.2M in total funding across 1 recorded rounds.
When did Vitrivax last raise?
Vitrivax last raised in Nov 2025 (Later Stage VC (Series B)), raising $29.4M.
Vitrivax Valuation 2026 — $69.4M | Private Market View